Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells.

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. Abstract Text:

Masanori Baba,Mika Okamoto,Takayuki Hamasaki,Sawako Horai,Xin Wang,Yuji Ito,Yasuo Suda,Naomichi Arima,

Human T-lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia (ATL). In Japan, the number of HTLV-1 carriers is estimated to be 1.2 million and more than 700 cases of ATL have been diagnosed every year. Considering the poor prognosis and lack of curative therapy of ATL, it seems mandatory to establish an effective strategy for the treatment of ATL. In this study, we attempted to identify the cell surface molecules that will become suitable targets of antibodies for anti-ATL therapy. The expression levels of approximately 40,000 host genes of three human T-cell lines carrying HTLV-1 genomes were analyzed by oligonucleotide microarray and compared with the expression levels of the genes in an HTLV-1-negative T-cell line. The HTLV-1-carrying T-cell lines used for experiments had totally different expression patterns of viral genome. Among the genes evaluated, the expression levels of 108 genes were found to be enhanced more than 10-fold in all of the T-cell lines examined and 11 of the 108 genes were considered to generate the proteins expressed on the cell surface. In particular, the CD70 gene was upregulated more than 1,000-fold and the enhanced expression of the CD70 molecule was confirmed by laser flow cytometry for various HTLV-1-carrying T-cell lines and primary CD4(+) T cells isolated from acute-type ATL patients. Such expression was not observed for primary CD4(+) T cells isolated from healthy donors. Since CD70 expression is strictly restricted in normal tissues, such as highly activated T and B cells, CD70 appears to be a potential target for effective antibody therapy against ATL.

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. Publishing Authors By Initials

M Baba,M Okamoto,T Hamasaki,S Horai,X Wang,Y Ito,Y Suda,N Arima,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of virology

VOLUME: 82

Page Numbers: 3843-52

Journal Abbreviation: J. Virol.

ISSN: 1098-5514

DAY: 6

MONTH: 02

YEAR: 2008

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 113724

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells.

AFFILIATION: Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1, Sakuragaoka, Kagoshima 890-8544, Japan. m-baba@vanilla.ocn.ne.jp

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Virol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells Related Publications

• Aberrant DNA methylation of imprinted loci in sperm from oligospermic patients.
• Aggressive NK cell leukaemia after splenectomy: association with CD95-resistant memory T-cell proliferation and recalcitrant clinical course of haemophagocytic syndrome.
• Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus.
• Correlated oxides: Sliding electrons take charge.
• Environment of tryptophan residues in alpha-lactalbumin.
• Evidence for the role of disulfide bonds in the masking of chromophore groups in bovine kappa-casein.
• Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL).
• Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells.
• Kinetic studies on the ES-complex formation of p-hydroxybenzoate hydroxylase using the stopped-flow method.
• L-Alloisocitrate dehydrogenase and oxalosuccinate decarboxylase from a Pseudomonas sp. utilizing L-alloisocitrate.
• Magnetic Control of Crystal Chirality and the Existence of a Large Magneto-Optical Dichroism Effect in CuB2O4.
• Polarization Reversal in Multiferroic TbMnO3 with a Rotating Magnetic Field Direction.
• Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA.
• Properties of the colicin E 2 -induced degradation of deoxyribonucleic acid in Escherichia coli.
• Pseudorotaxane-Like Supramolecular Complex of Coenzyme Q10 with gamma-Cyclodextrin Formed by Solubility Method.
• Purification of prorennin and production of its antibody.
• Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family.
• Split-root study of autoregulation of nodulation in the model legume Lotus japonicus.
• Studies on NADP-+-specific isocitrate dehydrogenase from an extreme thermophile, Thermus flavus AT-62.
• Studies on homoserine dehydrogenase from an extreme thermophile, Thermus flavus AT-62. Partial purification and properties.
• The structure and function of acid proteases. IV. Inactivation of the acid protease from Mucor pusillus by acid protease-specific inhibitors.
• Trastuzumab monotherapy versus combination therapy for treating recurrent breast cancer: time to progression and survival.
• Tryptic digestion of colicin E2 and its active fragment.
• [A comment on the qualification of the visiting nurse: a requirement for a minimum of 2 years in clinical experience]